Search research articles
Contact Us
Filters
Showing results (131-140 of 164) with videos related to
Page
of 17
Sort By:
The Journal of Clinical Investigation
|
November 19, 2024
An inducible RIPK3-driven necroptotic system enhances cancer cell-based immunotherapy and ensures safety
Kok-Siong Chen, Sarah Manoury-Battais, Nobuhiko Kanaya, et al.
Optics Letters
|
July 3, 2009
Feasibility of in vivo imaging of fluorescent proteins using lifetime contrast
Anand T N Kumar, Euiheon Chung, Scott B Raymond, et al.
Clinical Pharmacology and Therapeutics
|
September 29, 2025
Pharmacomicrobiomics
Naomi Gronich, Naama Geva-Zatorsky, Rachel Herren, et al.
Cancer Biology & Therapy
|
April 1, 2008
MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors
Adly Yacoub, Hossein Hamed, Luni Emdad, et al.
Molecular Cancer Therapeutics
|
January 8, 2010
Astrocyte elevated gene-1: a novel target for human glioma therapy
Luni Emdad, Devanand Sarkar, Seok-Geun Lee, et al.
Frontiers in Immunology
|
February 17, 2023
SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus
Almohanad A Alkayyal, Reham Ajina, Marco Cacciabue, et al.
Scientific Reports
|
January 16, 2019
Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy
Shota Tanaka, Samantha Luk, Juri Kiyokawa, et al.
Stem Cells Translational Medicine
|
June 13, 2023
Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer
Susana Moleirinho, Yohei Kitamura, Paulo S G N Borges, et al.
Ebiomedicine
|
January 18, 2026
A nanobody-stem cell platform targeting innate and adaptive immune axis in the tumour microenvironment
Ioulia Vogiatzi, Amelia Lehmann, Chuang Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2025
Anti-tumor immunity mediated by engineered allogeneic stem cells exploiting TRAIL-induced cell death and FLT3L immunomodulation
Thijs A van Schaik, Kok-Siong Chen, Nobuhiko Kanaya, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 164) with videos related to
Sort By:
Page
of 17
The Journal of Clinical Investigation
|
November 19, 2024
An inducible RIPK3-driven necroptotic system enhances cancer cell-based immunotherapy and ensures safety
Kok-Siong Chen, Sarah Manoury-Battais, Nobuhiko Kanaya, et al.
Optics Letters
|
July 3, 2009
Feasibility of in vivo imaging of fluorescent proteins using lifetime contrast
Anand T N Kumar, Euiheon Chung, Scott B Raymond, et al.
Clinical Pharmacology and Therapeutics
|
September 29, 2025
Pharmacomicrobiomics
Naomi Gronich, Naama Geva-Zatorsky, Rachel Herren, et al.
Cancer Biology & Therapy
|
April 1, 2008
MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors
Adly Yacoub, Hossein Hamed, Luni Emdad, et al.
Molecular Cancer Therapeutics
|
January 8, 2010
Astrocyte elevated gene-1: a novel target for human glioma therapy
Luni Emdad, Devanand Sarkar, Seok-Geun Lee, et al.
Frontiers in Immunology
|
February 17, 2023
SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus
Almohanad A Alkayyal, Reham Ajina, Marco Cacciabue, et al.
Scientific Reports
|
January 16, 2019
Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy
Shota Tanaka, Samantha Luk, Juri Kiyokawa, et al.
Stem Cells Translational Medicine
|
June 13, 2023
Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer
Susana Moleirinho, Yohei Kitamura, Paulo S G N Borges, et al.
Ebiomedicine
|
January 18, 2026
A nanobody-stem cell platform targeting innate and adaptive immune axis in the tumour microenvironment
Ioulia Vogiatzi, Amelia Lehmann, Chuang Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2025
Anti-tumor immunity mediated by engineered allogeneic stem cells exploiting TRAIL-induced cell death and FLT3L immunomodulation
Thijs A van Schaik, Kok-Siong Chen, Nobuhiko Kanaya, et al.
Page
of 17